During pregnancy, uterine fibroids may experience growth. These fibroids are common and often do not show any symptoms. However, in non-pregnant women, they can cause menorrhagia. In early pregnancy, they grow due to oestrogen and can cause pelvic pain and pressure. If they grow too quickly and surpass their blood supply, they may undergo ‘red degeneration’. This patient’s symptoms, including pelvic pain and a history of menorrhagia, suggest that the growth of pre-existing fibroids due to oestrogen may be the cause. However, further investigation with ultrasound is necessary to confirm this diagnosis. Ectopic pregnancies are rare in the second trimester and are typically detected during routine ultrasound scans. This patient is unlikely to have an ectopic pregnancy as her first ultrasound scan would have confirmed an intrauterine pregnancy. Pelvic inflammatory disease is not the most likely cause of this patient’s symptoms as it is associated with additional symptoms such as vaginal discharge and dysuria, and the patient would likely be febrile. The growth of pre-existing fibroids due to decreased progesterone is incorrect as progesterone, like oestrogen, is increased during pregnancy. This patient does not exhibit symptoms of dysuria, renal angle tenderness, or pyrexia.

Understanding Fibroid Degeneration

Uterine fibroids are non-cancerous growths that can develop in the uterus. They are sensitive to oestrogen and can grow during pregnancy. However, if the growth of the fibroids exceeds their blood supply, they can undergo a type of degeneration known as red or ‘carneous’ degeneration. This condition is characterized by symptoms such as low-grade fever, pain, and vomiting.

Fortunately, fibroid degeneration can be managed conservatively with rest and analgesia. With proper care, the symptoms should resolve within 4-7 days.

Treatment Regime for Moderately Severe Eczema with Superimposed Infection

Moderately severe eczema with evidence of superimposed infection requires a specific treatment regime. The severity of eczema is categorized into four categories: clear, mild, moderate, and severe. In this case, the patient has small areas of dry skin mainly in the flexures, and there is evidence of infected eczema/cellulitis with an erythematosus, weeping patch of skin in the lateral thigh.

The treatment regime should include a regular emollient ointment, such as Diprobase®, applied generously to the skin multiple times a day. Additionally, a moderately potent topical corticosteroid, such as betamethasone valerate 0.025% or clobetasone butyrate 0.05%, should be used sparingly on the inflamed areas once a day. The patient must be advised to apply the steroid first and allow 15-20 minutes for it to be absorbed before applying the emollient. Treatment should last 7-14 days and continue until 48 hours after the eczematous patches have cleared.

Furthermore, oral antibiotics are necessary for the treatment of infected eczema. Oral flucloxacillin is considered first-line, and treatment usually lasts for a 10-day period.

Treatment Regime for Moderately Severe Eczema with Superimposed Infection

Comparison of Pain Medications and their Risks for Gastrointestinal Bleeding

When it comes to managing pain in end-of-life care, it is important to consider the potential risks and side effects of different medications. One significant concern is the risk for gastrointestinal (GI) bleeding, which can be caused by certain pain medications.

Non-steroidal anti-inflammatory drugs (NSAIDs) are known to inhibit cyclo-oxygenase enzymes, which can decrease the level of protective prostaglandins in the GI tract and increase the risk for ulcers and bleeding. When combined with corticosteroids, this risk is even higher.

Buprenorphine, an opioid, does not cause gastric ulcers but can delay gastric emptying. Fentanyl, another opioid commonly used in patch form, has a short duration of action and is not typically associated with upper GI bleeding. Oxycontin, also an opioid, does not pose a bleeding risk when used alone but can be found in combination preparations with NSAIDs.

Tramadol, another opioid, is not commonly used in end-of-life care and is not associated with melaena (black, tarry stools).

Overall, it is important to carefully consider the risks and benefits of different pain medications when managing pain in end-of-life care, particularly when it comes to the potential for GI bleeding.

For women with atypical endometrial hyperplasia who are postmenopausal, it is recommended to undergo a total hysterectomy with bilateral salpingo-oophorectomy to prevent malignant progression. A total hysterectomy alone is not sufficient for postmenopausal women. It is also not recommended to undergo a bilateral salpingo-oophorectomy without removing the endometrium. A watch and wait approach is not advisable due to the potential for malignancy, and radiotherapy is not recommended as the condition is not yet malignant.

Endometrial hyperplasia is a condition where the endometrium, the lining of the uterus, grows excessively beyond what is considered normal during the menstrual cycle. This abnormal proliferation can lead to endometrial cancer in some cases. There are four types of endometrial hyperplasia: simple, complex, simple atypical, and complex atypical. Symptoms of this condition include abnormal vaginal bleeding, such as intermenstrual bleeding.

The management of endometrial hyperplasia depends on the type and severity of the condition. For simple endometrial hyperplasia without atypia, high dose progestogens may be prescribed, and repeat sampling is recommended after 3-4 months. The levonorgestrel intra-uterine system may also be used. However, if atypia is present, hysterectomy is usually advised.

Starting management for metastatic prostate cancer with GnRH agonists may lead to a phenomenon called tumour flare, which can cause bone pain, bladder obstruction, and other symptoms. This was observed in a 78-year-old man who presented with urinary retention and bone pain after recently starting treatment. GnRH agonists work by overstimulating the hormone cascade to suppress testosterone production, which initially causes an increase in testosterone levels before subsequent suppression. Bicalutamide is not the best answer as it does not cause the testosterone surge seen with GnRH agonist use. Bilateral orchidectomy is not typically associated with tumour flare as it aims to rapidly decrease testosterone levels. GnRH antagonists, such as degarelix, may be a better option as they avoid the risk of tumour flare by avoiding the testosterone surge.

Management of Prostate Cancer

Localised prostate cancer (T1/T2) can be managed through various treatment options depending on the patient’s life expectancy and preference. Conservative approaches such as active monitoring and watchful waiting can be considered, as well as radical prostatectomy and radiotherapy (external beam and brachytherapy). On the other hand, localised advanced prostate cancer (T3/T4) may require hormonal therapy, radical prostatectomy, or radiotherapy. However, patients who undergo radiotherapy may develop proctitis and are at a higher risk of bladder, colon, and rectal cancer.

For metastatic prostate cancer, the primary goal is to reduce androgen levels. A combination of approaches is often used, including anti-androgen therapy, synthetic GnRH agonist or antagonists, bicalutamide, cyproterone acetate, abiraterone, and bilateral orchidectomy. GnRH agonists such as Goserelin (Zoladex) may result in lower LH levels longer term by causing overstimulation, which disrupts endogenous hormonal feedback systems. This may cause a rise in testosterone initially for around 2-3 weeks before falling to castration levels. To prevent a rise in testosterone, anti-androgen therapy is often used initially. However, this may result in a tumour flare, which stimulates prostate cancer growth and may cause bone pain, bladder obstruction, and other symptoms. GnRH antagonists such as degarelix are being evaluated to suppress testosterone while avoiding the flare phenomenon. Chemotherapy with docetaxel may also be an option for the treatment of hormone-relapsed metastatic prostate cancer in patients who have no or mild symptoms after androgen deprivation therapy has failed, and before chemotherapy is indicated.

Treatment Options for Oral Candida Infection During Chemotherapy

During chemotherapy, patients may experience immunosuppression, which can lead to oral candida infection. There are several treatment options available for this condition, including oral fluconazole, nystatin mouthwash, and oral mycafungin. However, the most appropriate choice for mild to moderate oral candida infection is oral fluconazole, as it is more likely to prevent or delay recurrence than nystatin. Intravenous amphotericin B and oral voriconazole are not recommended for this condition, as they are used for systemic fungal infections and other types of fungal infections, respectively. It is important for healthcare providers to consider the patient’s individual needs and medical history when selecting a treatment option.

Stopping the combined oral contraceptive pill four weeks before the operation is recommended due to a higher likelihood of venous thromboembolism.

Preparation for surgery varies depending on whether the patient is undergoing an elective or emergency procedure. For elective cases, it is important to address any medical issues beforehand through a pre-admission clinic. Blood tests, urine analysis, and other diagnostic tests may be necessary depending on the proposed procedure and patient fitness. Risk factors for deep vein thrombosis should also be assessed, and a plan for thromboprophylaxis formulated. Patients are advised to fast from non-clear liquids and food for at least 6 hours before surgery, and those with diabetes require special management to avoid potential complications. Emergency cases require stabilization and resuscitation as needed, and antibiotics may be necessary. Special preparation may also be required for certain procedures, such as vocal cord checks for thyroid surgery or bowel preparation for colorectal cases.

The Koebner Phenomenon: Skin Conditions and Cutaneous Injury

The Koebner phenomenon is a term used to describe the appearance of new skin lesions in areas of cutaneous injury, often caused by scratching, in otherwise healthy skin. This phenomenon is commonly seen in skin conditions such as psoriasis, vitiligo, and lichen planus. It may also manifest in association with other conditions such as viral warts, pyoderma gangrenosum, and molluscum contagiosum.

In cases where the Koebner phenomenon occurs, the new lesions have the same clinical and histological features as the patient’s original skin disease. They are often linear in nature, following the route of cutaneous injury.

It is important to note that not all skin conditions exhibit the Koebner phenomenon. Rosacea, eczema, pityriasis rosea, and cellulitis are examples of skin conditions that do not exhibit this phenomenon.

In summary, the Koebner phenomenon is a unique characteristic of certain skin conditions that can occur in response to cutaneous injury. Understanding this phenomenon can aid in the diagnosis and management of these skin conditions.

If your child is experiencing any of the following symptoms, seek medical attention immediately:

– High fever (over 102°F or 39°C)
– Severe dehydration (signs include dry mouth, sunken eyes, and decreased urine output)
– Persistent severe respiratory distress, such as grunting, significant chest recession, or a respiratory rate exceeding 70 breaths per minute.

It is important to ensure your child is drinking enough fluids to avoid dehydration.

Bronchiolitis is a condition where the bronchioles become inflamed, and it is most commonly caused by respiratory syncytial virus (RSV). This virus is responsible for 75-80% of cases, with other causes including mycoplasma and adenoviruses. Bronchiolitis is most prevalent in infants under one year old, with 90% of cases occurring in those aged 1-9 months. The condition is more serious in premature babies, those with congenital heart disease or cystic fibrosis. Symptoms include coryzal symptoms, dry cough, increasing breathlessness, and wheezing. Hospital admission is often necessary due to feeding difficulties associated with increasing dyspnoea.

Immediate referral is recommended if the child has apnoea, looks seriously unwell, has severe respiratory distress, central cyanosis, or persistent oxygen saturation of less than 92% when breathing air. Clinicians should consider referral if the child has a respiratory rate of over 60 breaths/minute, difficulty with breastfeeding or inadequate oral fluid intake, or clinical dehydration. Immunofluorescence of nasopharyngeal secretions may show RSV, and management is largely supportive. Humidified oxygen is given via a head box if oxygen saturations are persistently low, and nasogastric feeding may be necessary if children cannot take enough fluid/feed by mouth. Suction may also be used for excessive upper airway secretions. NICE released guidelines on bronchiolitis in 2015 for more information.

Importance of Different Investigations in Assessing Acute Respiratory Failure

When a patient presents with acute respiratory failure, it is important to conduct various investigations to determine the underlying cause and severity of the condition. Among the different investigations, arterial blood gas (ABG) is the most important as it helps assess the partial pressures of oxygen and carbon dioxide, as well as the patient’s pH level. This information can help classify respiratory failure into type I or II and identify potential causes of respiratory deterioration. In patients with a history of COPD, ABG can also determine if they are retaining carbon dioxide, which affects their target oxygen saturations.

While a chest X-ray may be considered to assess for underlying pathology, it is not the most important investigation. A D-dimer may be used to rule out pulmonary embolism, and an electrocardiogram (ECG) may be done to assess for cardiac causes of respiratory failure. However, ABG should be prioritized before these investigations.

Pulmonary function tests may be required after initial assessment of oxygen saturations to predict potential respiratory failure based on the peak expiratory flow rate. Overall, a combination of these investigations can help diagnose and manage acute respiratory failure effectively.